These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 15694230

  • 21. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R, Balanzá-Martínez V, Sánchez-Moreno J, Martinez-Aran A, Salazar-Fraile J, Selva-Vera G, Rubio C, Mata I, Gómez-Beneyto M, Vieta E.
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [Abstract] [Full Text] [Related]

  • 22. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP, Kosmidis MH, Giannakou M, Anezoulaki D, Petrikis P, Fokas K, Karavatos A.
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [Abstract] [Full Text] [Related]

  • 23. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.
    Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW.
    Int J STD AIDS; 2004 Apr; 15(4):254-9. PubMed ID: 15075020
    [Abstract] [Full Text] [Related]

  • 24. Substance abuse and cognitive functioning in schizophrenia.
    Addington J, Addington D.
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [Abstract] [Full Text] [Related]

  • 25. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP, Kosmidis MH, Kafantari A, Gamvrula K, Vasiliadou E, Petrikis P, Fokas K, Karavatos A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
    [Abstract] [Full Text] [Related]

  • 26. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF, Cheng CP, Huang CF, Yen JY, Ko CH, Chen CS.
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [Abstract] [Full Text] [Related]

  • 27. Relations between a computerized shopping task and cognitive tests in a group of persons diagnosed with schizophrenia compared with healthy controls.
    Larøi F, Canlaire J, Mourad H, VAN DER Linden M.
    J Int Neuropsychol Soc; 2010 Jan; 16(1):180-9. PubMed ID: 19900350
    [Abstract] [Full Text] [Related]

  • 28. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL.
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [Abstract] [Full Text] [Related]

  • 29. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N, Baskurt F, Baskurt Z, Ozakbas S, Idiman E.
    J Neurol Sci; 2006 Jul 15; 246(1-2):117-22. PubMed ID: 16678208
    [Abstract] [Full Text] [Related]

  • 30. Contribution of divergent thinking to community functioning in schizophrenia.
    Nemoto T, Kashima H, Mizuno M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):517-24. PubMed ID: 17218048
    [Abstract] [Full Text] [Related]

  • 31. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E.
    Bipolar Disord; 2007 Mar 30; 9(1-2):63-70. PubMed ID: 17391351
    [Abstract] [Full Text] [Related]

  • 32. Cognitive dysfunctions in patients with obsessive-compulsive disorder compared to the patients with schizophrenia patients: relation to overvalued ideas.
    Kitis A, Akdede BB, Alptekin K, Akvardar Y, Arkar H, Erol A, Kaya N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):254-61. PubMed ID: 16914246
    [Abstract] [Full Text] [Related]

  • 33. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM, Barabash A, Martínez-Vizcaíno V, Tabarés-Seisdedos R, Balanzá-Martínez V, Cabranes-Díaz JA, Baca-Baldomero E, Gómez JL.
    Psychiatry Res; 2009 Oct 30; 169(3):220-8. PubMed ID: 19758705
    [Abstract] [Full Text] [Related]

  • 34. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG, Testa SM, Meyer SM, Rao VA, Diaz-Asper CM, Pearlson GD, Schretlen DJ.
    J Psychiatr Res; 2008 Sep 30; 42(11):930-7. PubMed ID: 18021807
    [Abstract] [Full Text] [Related]

  • 35. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J, Bembenek A, Hintze B, Kühn-Dymecka A.
    Psychiatr Pol; 2006 Sep 30; 40(5):867-84. PubMed ID: 17217232
    [Abstract] [Full Text] [Related]

  • 36. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.
    Herman M.
    Int J Ment Health Nurs; 2004 Dec 30; 13(4):282-91. PubMed ID: 15660598
    [Abstract] [Full Text] [Related]

  • 37. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
    Hanuszkiewicz I, Cechnicki A, Kalisz A.
    Psychiatr Pol; 2007 Dec 30; 41(4):539-50. PubMed ID: 18046984
    [Abstract] [Full Text] [Related]

  • 38. Neuropsychological profile of cognitively impaired patients with schizophrenia.
    Bozikas VP, Kosmidis MH, Kiosseoglou G, Karavatos A.
    Compr Psychiatry; 2006 Dec 30; 47(2):136-43. PubMed ID: 16490572
    [Abstract] [Full Text] [Related]

  • 39. Insight, quality of life and cognitive functioning in euthymic patients with bipolar disorder.
    Dias VV, Brissos S, Frey BN, Kapczinski F.
    J Affect Disord; 2008 Sep 30; 110(1-2):75-83. PubMed ID: 18272231
    [Abstract] [Full Text] [Related]

  • 40. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL, Heinrichs RW.
    Compr Psychiatry; 2004 Sep 30; 45(5):415-21. PubMed ID: 15332206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.